X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (64) 64
female (48) 48
male (47) 47
index medicus (46) 46
hematology (41) 41
middle aged (41) 41
aged (36) 36
life sciences (33) 33
adult (32) 32
treatment outcome (24) 24
immunology (22) 22
oncology (20) 20
[ sdv.imm ] life sciences [q-bio]/immunology (17) 17
aged, 80 and over (17) 17
cancer (15) 15
mesh : humans (15) 15
leukemia, myeloid, acute - drug therapy (14) 14
chemotherapy (13) 13
transplantation (13) 13
abridged index medicus (12) 12
disease-free survival (12) 12
leukemia (12) 12
prognosis (12) 12
adolescent (11) 11
stem cells (11) 11
hematology, oncology and palliative medicine (10) 10
leukemia, myeloid, acute - mortality (10) 10
retrospective studies (10) 10
young adult (10) 10
acute myeloid leukemia (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (9) 9
kaplan-meier estimate (9) 9
leukemia, myeloid, acute - genetics (9) 9
mesh : female (9) 9
mesh : male (9) 9
survival rate (9) 9
aml (8) 8
mutation (8) 8
precursor cell lymphoblastic leukemia-lymphoma (8) 8
recurrence (8) 8
survival analysis (8) 8
acute myeloid-leukemia (7) 7
analysis (7) 7
follow-up studies (7) 7
france (7) 7
leukemia, myeloid, acute (7) 7
myelodysplastic syndromes - drug therapy (7) 7
remission induction (7) 7
time factors (7) 7
[sdv.can]life sciences [q-bio]/cancer (6) 6
acute disease (6) 6
bone marrow (6) 6
expression (6) 6
mesh : aged (6) 6
mesh : leukemia, myeloid, acute (6) 6
mesh : middle aged (6) 6
mesh : precursor cell lymphoblastic leukemia-lymphoma (6) 6
polymerase chain reaction (6) 6
precursor cell lymphoblastic leukemia-lymphoma - pathology (6) 6
risk factors (6) 6
stem-cell transplantation (6) 6
1st complete remission (5) 5
adult patients (5) 5
blast crisis (5) 5
cohort studies (5) 5
hematopoietic stem cell transplantation (5) 5
hematopoietic stem cells (5) 5
hemic and lymphatic diseases (5) 5
human health and pathology (5) 5
leukemia, myeloid, acute - pathology (5) 5
mesh : adult (5) 5
mesh : blast crisis (5) 5
older patients (5) 5
patients (5) 5
prospective studies (5) 5
response criteria (5) 5
reverse transcriptase polymerase chain reaction (5) 5
societies, medical (5) 5
survival (5) 5
trial (5) 5
acute myelogenous leukemia (4) 4
anti-bacterial agents - therapeutic use (4) 4
antimetabolites, antineoplastic - therapeutic use (4) 4
antineoplastic agents (4) 4
antineoplastic agents - therapeutic use (4) 4
antineoplastic combined chemotherapy protocols (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
apoptosis (4) 4
azacitidine (4) 4
azacitidine - therapeutic use (4) 4
bone-marrow-transplantation (4) 4
child (4) 4
classification (4) 4
cytogenetics (4) 4
daunorubicin - administration & dosage (4) 4
diagnosis (4) 4
elderly-patients (4) 4
france - epidemiology (4) 4
hematopoietic stem cell transplantation - adverse effects (4) 4
human leukemic blasts (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2012, Volume 379, Issue 9825, pp. 1508 - 1516
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 808 - 814
Journal Article
Intensive Care Medicine, ISSN 0342-4642, 11/2017, Volume 43, Issue 11, pp. 1613 - 1625
Microbiological diagnosis (MD) of infections remains insufficient. The resulting empirical antimicrobial therapy leads to multidrug resistance and... 
Pediatrics | Pain Medicine | Emergency Medicine | Pneumology/Respiratory System | Medicine & Public Health | Intensive / Critical Care Medicine | Sepsis | Anesthesiology | Aetiological source | Bacteremia | PCR | DIAGNOSIS | COST-EFFECTIVENESS | GUIDELINES | NEUTROPENIC PATIENTS | DE-ESCALATION | DISEASES SOCIETY | SEPTIC SHOCK | BLOOD-STREAM INFECTIONS | EPIDEMIOLOGY | SEVERE SEPSIS | CRITICAL CARE MEDICINE | Endocarditis - blood | Febrile Neutropenia - mortality | Humans | Middle Aged | Sepsis - diagnosis | Intensive Care Units - statistics & numerical data | Male | Molecular Diagnostic Techniques - economics | Time-to-Treatment - economics | Anti-Bacterial Agents - therapeutic use | Endocarditis - diagnosis | Time Factors | Endocarditis - mortality | Female | Retrospective Studies | Febrile Neutropenia - diagnosis | Hospital Mortality | Risk Factors | Sepsis - mortality | Cross-Over Studies | Febrile Neutropenia - blood | Quality Improvement | Cost-Benefit Analysis | Intention to Treat Analysis | Aged | Sepsis - blood | Diagnosis | Health aspects | Endocarditis | Health care | Intervention | Pathogens | Multidrug resistance | Infections | Clustering | Patients | Empirical analysis | Blood | Confidence intervals | Randomization | Multilevel | Clusters | Diagnostic systems | Cost analysis | Neutropenia | Life Sciences | Microbiology and Parasitology | Mycology | Original
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 07/2019
TKI discontinuation is an emerging goal in CML management and several studies demonstrated the feasibility of stopping safely imatinib. A sustained DMR on... 
Journal Article
Nutrition, ISSN 0899-9007, 2017, Volume 41, pp. 120 - 125
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 11/2019, Volume 25, Issue 22, pp. 6606 - 6613
Purpose: Tyrosine kinase inhibitor (TKI) discontinuation is an emerging goal in chronic myelogenous leukemia (CML) management and several studies have... 
RELAPSE | ONCOLOGY | DISCONTINUATION | CHRONIC MYELOID-LEUKEMIA | REMISSION | Life Sciences | Hematology | Human health and pathology
Journal Article
Blood, ISSN 0006-4971, 08/2014, Volume 124, Issue 9, pp. 1426 - 1433
Journal Article
Revue Neurologique, ISSN 0035-3787, 04/2018, Volume 174, pp. S141 - S141
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 12/2017, Volume 318, Issue 21, pp. 2099 - 2110
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2008, Volume 26, Issue 32, pp. 5192 - 5197
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2015, Volume 90, Issue 9, pp. 811 - 818
Purpose: The GRASPALL/GRAALL‐SA2‐2008 Phase II trial evaluated the safety and efficacy of L‐asparaginase encapsulated within erythrocytes (GRASPA®) in patients... 
ADULT PATIENTS | THERAPY | OLDER PATIENTS | COLI ASPARAGINASE | DOXORUBICIN | RANDOMIZED-TRIAL | REGIMEN | RED-BLOOD-CELLS | HEMATOLOGY | MINIMAL RESIDUAL DISEASE | CHILDRENS ONCOLOGY GROUP | Humans | Middle Aged | Gram-Positive Bacterial Infections - mortality | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Erythrocytes - chemistry | Antifungal Agents - therapeutic use | Drug Carriers | Anti-Bacterial Agents - therapeutic use | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Drug Compounding | Erythrocytes - cytology | Female | Gram-Positive Bacterial Infections - complications | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | Asparaginase - therapeutic use | Philadelphia Chromosome | Precursor Cell Lymphoblastic Leukemia-Lymphoma - complications | Gram-Negative Bacterial Infections - pathology | Antineoplastic Combined Chemotherapy Protocols | Gram-Negative Bacterial Infections - complications | Gram-Negative Bacterial Infections - drug therapy | Remission Induction | Gram-Positive Bacterial Infections - pathology | Asparagine - metabolism | Mycoses - pathology | Mycoses - drug therapy | Survival Analysis | Aged | Mycoses - complications | Mycoses - mortality | Gram-Positive Bacterial Infections - drug therapy | Gram-Negative Bacterial Infections - mortality | Oncology, Experimental | Clinical trials | Genetic research | Asparagine | Aged patients | Genetic aspects | Acute lymphocytic leukemia | Research | Cancer | Index Medicus | Life Sciences
Journal Article